Maladie de Chagas : Questions médicales fréquentes
Nom anglais: Chagas Disease
Descriptor UI:D014355
Tree Number:C01.920.625
Termes MeSH sélectionnés :
Cluster Headache
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Chagas : Questions médicales les plus fréquentes",
"headline": "Maladie de Chagas : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladie de Chagas : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-25",
"dateModified": "2025-03-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladie de Chagas"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies vectorielles",
"url": "https://questionsmedicales.fr/mesh/D000079426",
"about": {
"@type": "MedicalCondition",
"name": "Maladies vectorielles",
"code": {
"@type": "MedicalCode",
"code": "D000079426",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.920"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Chagas",
"alternateName": "Chagas Disease",
"code": {
"@type": "MedicalCode",
"code": "D014355",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Israel Molina",
"url": "https://questionsmedicales.fr/author/Israel%20Molina",
"affiliation": {
"@type": "Organization",
"name": "Tropical Medicine Unit, Department of Infectious Diseases, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain; Instituto René Rachou-FIOCRUZ Minas, Chagas Disease Research Group, Belo Horizonte, MG, Brazil."
}
},
{
"@type": "Person",
"name": "Eva H Clark",
"url": "https://questionsmedicales.fr/author/Eva%20H%20Clark",
"affiliation": {
"@type": "Organization",
"name": "Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA."
}
},
{
"@type": "Person",
"name": "Caryn Bern",
"url": "https://questionsmedicales.fr/author/Caryn%20Bern",
"affiliation": {
"@type": "Organization",
"name": "Department of Epidemiology and Biostatistics, University of California San Francisco School of Medicine, San Francisco, California, USA."
}
},
{
"@type": "Person",
"name": "Carlos A Morillo",
"url": "https://questionsmedicales.fr/author/Carlos%20A%20Morillo",
"affiliation": {
"@type": "Organization",
"name": "Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Foothills Medical Centre, Room C823, 1403 29th Street Northwest, Calgary, Alberta T2N 2T9, Canada. Electronic address: carlos.morillo@ucalgary.ca."
}
},
{
"@type": "Person",
"name": "Susan P Montgomery",
"url": "https://questionsmedicales.fr/author/Susan%20P%20Montgomery",
"affiliation": {
"@type": "Organization",
"name": "Parasitic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia (S.P.M.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "CGRP-Targeted Therapy for Episodic and Chronic Cluster Headache.",
"datePublished": "2022-07-26",
"url": "https://questionsmedicales.fr/article/35881279",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11916-022-01070-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Substance use related cluster headache: A case series.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35856604",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/head.14364"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reduced expression of inflammasome complex components in cluster headache.",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35670197",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/head.14334"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pre-cluster symptoms in a Taiwanese cohort of cluster headache: symptom profiles and clinical predictions.",
"datePublished": "2024-10-08",
"url": "https://questionsmedicales.fr/article/39379823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s10194-024-01862-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ).",
"datePublished": "2023-03-20",
"url": "https://questionsmedicales.fr/article/36939946",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10072-023-06758-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vectorielles",
"item": "https://questionsmedicales.fr/mesh/D000079426"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladie de Chagas",
"item": "https://questionsmedicales.fr/mesh/D014355"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladie de Chagas - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladie de Chagas",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladie de Chagas",
"description": "Comment diagnostique-t-on la maladie de Chagas ?\nQuels examens sont utilisés pour le diagnostic ?\nPeut-on diagnostiquer la maladie par biopsie ?\nQuels sont les signes cliniques au diagnostic ?\nLa maladie de Chagas est-elle toujours symptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D014355?mesh_terms=Cluster+Headache&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladie de Chagas",
"description": "Quels sont les symptômes aigus de la maladie de Chagas ?\nQuels symptômes chroniques peuvent apparaître ?\nY a-t-il des symptômes cutanés associés ?\nComment se manifeste l'œdème de l'œil ?\nLes symptômes varient-ils selon les régions ?",
"url": "https://questionsmedicales.fr/mesh/D014355?mesh_terms=Cluster+Headache&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladie de Chagas",
"description": "Comment prévenir la maladie de Chagas ?\nLes moustiquaires sont-elles efficaces ?\nL'éducation sanitaire joue-t-elle un rôle ?\nLes tests de dépistage sont-ils importants ?\nPeut-on prévenir la transmission par voie orale ?",
"url": "https://questionsmedicales.fr/mesh/D014355?mesh_terms=Cluster+Headache&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladie de Chagas",
"description": "Quel est le traitement principal de la maladie de Chagas ?\nLe traitement est-il efficace à tous les stades ?\nY a-t-il des effets secondaires au traitement ?\nDes traitements alternatifs existent-ils ?\nLe traitement prévient-il les complications ?",
"url": "https://questionsmedicales.fr/mesh/D014355?mesh_terms=Cluster+Headache&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladie de Chagas",
"description": "Quelles sont les complications cardiaques possibles ?\nLa maladie peut-elle affecter le système digestif ?\nY a-t-il des risques de décès liés à la maladie ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D014355?mesh_terms=Cluster+Headache&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladie de Chagas",
"description": "Quels sont les principaux facteurs de risque ?\nLes voyages dans certaines régions augmentent-ils le risque ?\nLes conditions de vie influencent-elles le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes personnes immunodéprimées sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D014355?mesh_terms=Cluster+Headache&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la maladie de Chagas ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques pour détecter les anticorps anti-T. cruzi."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'ELISA, l'immunofluorescence et la PCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer la maladie par biopsie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une biopsie de tissu peut révéler la présence du parasite dans certains cas."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques au diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent inclure des œdèmes, des éruptions cutanées et des symptômes cardiaques."
}
},
{
"@type": "Question",
"name": "La maladie de Chagas est-elle toujours symptomatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle peut être asymptomatique pendant des années avant d'entraîner des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes aigus de la maladie de Chagas ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent fièvre, fatigue, et gonflement au site de la piqûre."
}
},
{
"@type": "Question",
"name": "Quels symptômes chroniques peuvent apparaître ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes chroniques incluent des problèmes cardiaques et digestifs, comme l'arythmie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et des lésions peuvent se développer, surtout au stade aigu."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'œdème de l'œil ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'œdème de l'œil, ou signe de Romaña, se manifeste par un gonflement autour de l'œil."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les régions ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la souche du parasite et de l'hôte."
}
},
{
"@type": "Question",
"name": "Comment prévenir la maladie de Chagas ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'amélioration des conditions de logement et l'utilisation d'insecticides."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les moustiquaires peuvent réduire le contact avec les insectes vecteurs de la maladie."
}
},
{
"@type": "Question",
"name": "L'éducation sanitaire joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques et les méthodes de prévention est cruciale pour réduire l'incidence."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage des donneurs de sang et des femmes enceintes est essentiel pour prévenir la transmission."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la transmission par voie orale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter la consommation d'aliments contaminés peut prévenir la transmission orale de la maladie."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de la maladie de Chagas ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'utilisation de médicaments antiparasitaires comme le benznidazole."
}
},
{
"@type": "Question",
"name": "Le traitement est-il efficace à tous les stades ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est plus efficace au stade aigu; son efficacité diminue au stade chronique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires au traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des éruptions cutanées et des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs sont en cours d'étude, mais le benznidazole reste le standard."
}
},
{
"@type": "Question",
"name": "Le traitement prévient-il les complications ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce peut réduire le risque de complications à long terme, comme les problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications cardiaques possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications cardiaques incluent l'insuffisance cardiaque, les arythmies et la cardiomyopathie."
}
},
{
"@type": "Question",
"name": "La maladie peut-elle affecter le système digestif ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications digestives comme l'agrandissement de l'œsophage ou du côlon peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de décès liés à la maladie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications graves peuvent entraîner la mort, surtout si non traitées."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup sont irréversibles sans traitement précoce."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie, limitant les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la pauvreté, le manque d'accès à des logements sains et l'exposition aux insectes vecteurs."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'exposition au parasite."
}
},
{
"@type": "Question",
"name": "Les conditions de vie influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des habitations en terre ou en bois augmente le risque d'infestation par les triatomes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents familiaux de la maladie peut augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées peuvent être plus susceptibles de développer des formes graves de la maladie."
}
}
]
}
]
}
Chronic cluster headache (CH) substantially affects patients' quality of life, and treatment remains challenging. The current article reviewed controlled studies for new treatment options targeting ca...
Two anti-CGRP monoclonal antibodies (i.e., galcanezumab and fremanezumab) completed randomized-control trials for efficacy for the preventive treatment of episodic and chronic CH. Galcanezumab was eff...
Essential oils (EOs) with pro-convulsant properties are known to cause seizures and may worsen migraine. Here we report five cases of cluster headache (CH) secondary to the usage of toothpastes contai...
Patients were identified from the headache clinics of three tertiary care hospitals in south India. Detailed history, examination, and brain magnetic resonance imaging were done in all patients. CH wa...
We had five cases of EO-related CH (EORCH), from February 2020 to August 2021; three females and two males, with age ranging from 19 to 54 years. Three had new onset CH, while two had previous cluster...
EOs with pro-convulsive properties may trigger and sustain CH. Physicians may consider inquiring about the exposure to these pro-convulsant EOs in patients with CH and may consider advising the discon...
The involvement of inflammation in the pathophysiology of cluster headache (CH) has been suggested, with a role implied for interleukin (IL)-1β. We aimed to measure peripheral blood expression levels ...
In this cross-sectional study conducted in the Headache Unit of Istanbul University, Turkey, blood mononuclear cells (PBMCs) and sera were collected from 30 patients with episodic migraine, 4 with chr...
NLRP3 expression levels were significantly reduced in PBMC samples of patients with CH, obtained during CH attacks (n = 24) or headache-free (out of cycle) episodes (n = 10). CH-attack patients showed...
Our results support the involvement of the IL-1β system in attacks of CH. However, the components of the inflammasome complex are suppressed in the peripheral blood and do not appear to play a role in...
Pre-cluster symptoms (PCSs) are symptoms preceding cluster bouts and might have implications for the treatment of cluster headache (CH). This study investigated the prevalence of PCSs, and their utili...
We prospectively collected data from patients with CH. Each patient received a structured interview and completed questionnaire surveys during CH bouts. In sub-study 1, we cross-sectionally analyzed t...
A total of 168 CH patients (women/men: 39/129) completed the study. In sub-study 1, we found 149 (88.7%) experienced PCSs, with a median of 24 (IQR 18 to 72) hours before the bouts. Up to 57.7% of pat...
PCSs were very common in CH and could be used to predict upcoming bouts. Different symptom categories of PCSs may have different clinical implications....
The Cluster Headache Impact Questionnaire (CHIQ) is a specific and easy-to-use questionnaire to assess the current impact of cluster headache (CH). The aim of this study was to validate the Italian ve...
We included patients diagnosed with episodic CH (eCH) or chronic CH (cCH) according to the ICHD-3 criteria and included in the "Italian Headache Registry" (RICe). The questionnaire was administered to...
We included 181 patients subdivided in 96 patients with active eCH, 14 with cCH, and 71 with eCH in remission. The 110 patients with either active eCH or cCH were included in the validation cohort; on...
Our data show the validity of the Italian version of the CHIQ, which represents a suitable tool for evaluating the social and psychological impact of CH in clinical practice and research....
To examine factors for adherent and non-adherent behavior in patients with cluster headache and migraine. Adults with cluster headache or migraine were included in this anonymous online survey using a...
Converging evidence suggests that anatomical and functional mesocorticolimbic abnormalities support the chronicization of pain disorders....
We mapped structural and functional alterations of the mesocorticolimbic system in a sample of chronic cluster headache patients (n = 28) in comparison to age and sex-matched healthy individuals (n = ...
Univariate logistic regression models showed that several of the examined structures/areas (i.e., the bilateral nucleus accumbens, ventral diencephalon, hippocampus, and frontal pole, and the right am...
Our results showed that chronic cluster headache patients present anatomical and functional maladaptation of the mesocorticolimbic system, with functional data indicating a possible prefrontal areas' ...
Cluster headache is a less-prevalent primary headache disorder but is overrepresented with regards to use of health care and social services. More insight into the socioeconomic impact is required....
We investigated both the personal and societal disease burden and cost in 400 patients with well-classified cluster headache according to the ICHD-criteria and 200 sex- and age matched controls. All p...
Patients with chronic cluster headache constituted 146 out of 400 (37%). Overall, restriction in personal and/or professional life was reported by 94% of patients during attack periods. Even in remiss...
Cluster headache has a major negative impact on personal life, self-perceived health, and societal cost. Patients with the chronic variant are vastly more burdened. Patients with the episodic form wer...
Cluster headache (CH) is usually comorbid to mood spectrum disorders, but the psychopathological aspects are poorly explored. We aimed at identifying discrete profiles of personality traits and their ...
Based on the personality scales of the Millon Clinical Multiaxial Inventory-III, principal component analysis (PCA) identified psychological patterns of functioning of 56 CH patients. PCA outcomes wer...
Eighty-seven percent of patients had personality dysfunctions. PCA found two bipolar patterns: (i) negativistic, sadic-aggressive, borderline, and compulsive traits were distinctive of the psychologic...
Personality disorders are common in CH. Our data-driven approach revealed distinct personality patterns which can appear differently among patients. The worst combination arguing against mental health...
Cluster headache (CH) is included under section 3 - Trigeminal autonomic cephalalgias (TAC) of the International Headache Society (IHS) classification. It is one of the most frequent, painful and disa...